Effects of 17β-oestradiol on rat isolated coronary and mesenteric artery tone: Involvement of nitric oxide

Donna Otter, Clare Austin

Research output: Contribution to journalArticleResearchpeer-review

30 Citations (Scopus)

Abstract

Pre- and post-menopausal women receiving oestrogen replacement therapy have a significantly reduced risk of cardiovascular disorders. It has been suggested that this protection might be partly a result of a direct relaxant effect of oestrogens on coronary arteries. This study examines and directly compares the effects of 17β-oestradiol on rat isolated coronary and mesenteric vessels. The influence of nitric oxide on these responses was also investigated. 17β-Oestradiol caused similar concentration-dependent relaxation of isolated coronary and mesenteric resistance arteries pre-contracted with either KCl (60 mM) or 9,11-dideoxy-11α,9α-epoxymethanoprostaglandin (U46619; 1 μM). The relaxation responses to 17β-oestradiol were significantly reduced, but not totally inhibited, in the presence of N(ω)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase; they were not altered by indomethacin, an inhibitor of prostaglandin synthesis. The responses to 17β-oestradiol in the presence of L-NAME were not dependent on the vessel studied or the precontracting agent used. These results suggest that nitric oxide might contribute to the vasodilatory effects of 17β-oestradiol in rat isolated coronary and mesenteric resistance arteries.

Original languageEnglish
Pages (from-to)531-538
Number of pages8
JournalJournal of Pharmacy and Pharmacology
Volume50
Issue number5
DOIs
Publication statusPublished - May 1998
Externally publishedYes

Fingerprint

Mesenteric Arteries
Estradiol
Coronary Vessels
Nitric Oxide
NG-Nitroarginine Methyl Ester
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Prostaglandin Antagonists
Estrogen Replacement Therapy
Nitric Oxide Synthase
Indomethacin
Estrogens

Cite this

@article{342ce47d975d4b7194e3ce1ed9e59a26,
title = "Effects of 17β-oestradiol on rat isolated coronary and mesenteric artery tone: Involvement of nitric oxide",
abstract = "Pre- and post-menopausal women receiving oestrogen replacement therapy have a significantly reduced risk of cardiovascular disorders. It has been suggested that this protection might be partly a result of a direct relaxant effect of oestrogens on coronary arteries. This study examines and directly compares the effects of 17β-oestradiol on rat isolated coronary and mesenteric vessels. The influence of nitric oxide on these responses was also investigated. 17β-Oestradiol caused similar concentration-dependent relaxation of isolated coronary and mesenteric resistance arteries pre-contracted with either KCl (60 mM) or 9,11-dideoxy-11α,9α-epoxymethanoprostaglandin (U46619; 1 μM). The relaxation responses to 17β-oestradiol were significantly reduced, but not totally inhibited, in the presence of N(ω)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase; they were not altered by indomethacin, an inhibitor of prostaglandin synthesis. The responses to 17β-oestradiol in the presence of L-NAME were not dependent on the vessel studied or the precontracting agent used. These results suggest that nitric oxide might contribute to the vasodilatory effects of 17β-oestradiol in rat isolated coronary and mesenteric resistance arteries.",
author = "Donna Otter and Clare Austin",
year = "1998",
month = "5",
doi = "10.1111/j.2042-7158.1998.tb06195.x",
language = "English",
volume = "50",
pages = "531--538",
journal = "Pharmacy and Pharmacology Communications",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "5",

}

Effects of 17β-oestradiol on rat isolated coronary and mesenteric artery tone : Involvement of nitric oxide. / Otter, Donna; Austin, Clare.

In: Journal of Pharmacy and Pharmacology, Vol. 50, No. 5, 05.1998, p. 531-538.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Effects of 17β-oestradiol on rat isolated coronary and mesenteric artery tone

T2 - Involvement of nitric oxide

AU - Otter, Donna

AU - Austin, Clare

PY - 1998/5

Y1 - 1998/5

N2 - Pre- and post-menopausal women receiving oestrogen replacement therapy have a significantly reduced risk of cardiovascular disorders. It has been suggested that this protection might be partly a result of a direct relaxant effect of oestrogens on coronary arteries. This study examines and directly compares the effects of 17β-oestradiol on rat isolated coronary and mesenteric vessels. The influence of nitric oxide on these responses was also investigated. 17β-Oestradiol caused similar concentration-dependent relaxation of isolated coronary and mesenteric resistance arteries pre-contracted with either KCl (60 mM) or 9,11-dideoxy-11α,9α-epoxymethanoprostaglandin (U46619; 1 μM). The relaxation responses to 17β-oestradiol were significantly reduced, but not totally inhibited, in the presence of N(ω)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase; they were not altered by indomethacin, an inhibitor of prostaglandin synthesis. The responses to 17β-oestradiol in the presence of L-NAME were not dependent on the vessel studied or the precontracting agent used. These results suggest that nitric oxide might contribute to the vasodilatory effects of 17β-oestradiol in rat isolated coronary and mesenteric resistance arteries.

AB - Pre- and post-menopausal women receiving oestrogen replacement therapy have a significantly reduced risk of cardiovascular disorders. It has been suggested that this protection might be partly a result of a direct relaxant effect of oestrogens on coronary arteries. This study examines and directly compares the effects of 17β-oestradiol on rat isolated coronary and mesenteric vessels. The influence of nitric oxide on these responses was also investigated. 17β-Oestradiol caused similar concentration-dependent relaxation of isolated coronary and mesenteric resistance arteries pre-contracted with either KCl (60 mM) or 9,11-dideoxy-11α,9α-epoxymethanoprostaglandin (U46619; 1 μM). The relaxation responses to 17β-oestradiol were significantly reduced, but not totally inhibited, in the presence of N(ω)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase; they were not altered by indomethacin, an inhibitor of prostaglandin synthesis. The responses to 17β-oestradiol in the presence of L-NAME were not dependent on the vessel studied or the precontracting agent used. These results suggest that nitric oxide might contribute to the vasodilatory effects of 17β-oestradiol in rat isolated coronary and mesenteric resistance arteries.

UR - http://www.scopus.com/inward/record.url?scp=0031595222&partnerID=8YFLogxK

U2 - 10.1111/j.2042-7158.1998.tb06195.x

DO - 10.1111/j.2042-7158.1998.tb06195.x

M3 - Article

VL - 50

SP - 531

EP - 538

JO - Pharmacy and Pharmacology Communications

JF - Pharmacy and Pharmacology Communications

SN - 0022-3573

IS - 5

ER -